Clinical Trials Sponsored by Kona Medical Inc.

Total 2969 results

Kona Medical Inc.

Unknown

Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension

Hypertension
Kona Medical Inc.

Completed

Renal Denervation Using Externally Focused Therapeutic Ultrasound

Hypertension

Czech Republic, New Zealand
Kona Medical Inc.

Unknown

Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension (WAVE_IV)

Hypertension

Germany, United Kingdom, Poland, Australia, Austria, Colombia, Czech Republic, New Zealand
Kona Medical Inc.

Completed

Feasibility Study to Evaluate Renal Denervation Using Focused Ultrasound

Hypertension

Canada, Australia, Czech Republic
Kona Medical Inc.

Completed

A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension

Hypertension

Australia
Koya Medical, Inc.

Recruiting

A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema (NILE)

Lymphedema | Lymphedema of Upper Arm | Lymphedema, Breast Cancer

United States
Koya Medical, Inc.

Recruiting

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery (TIGRIS)

Lymphedema | Lymphedema, Breast Cancer | Lymphedema Arm

United States
Koya Medical, Inc.

Recruiting

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Insight® Pro Device for Evaluating Lymphatic and Venous Disorders (VOLGA) (VOLGA)

Lymphedema | Edema | Venous Insufficiency of Leg | Chronic Venous Insufficiency

United States
Koya Medical, Inc.

Completed

A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema (TEAYS)

Lymphedema | Venous Insufficiency | Chronic Venous Insufficiency | Lymphedema, Lower Limb | Lymphedema of Leg

United States
Koya Medical, Inc.

Completed

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema (TIBER)

Lymphedema | Secondary Lymphedema | Chronic Venous Insufficiency | Lymphedema Lower Extremity

United States
Koya Medical, Inc.

Completed

Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study (DAYSPRING)

Quality of Life | Lymphedema | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema

United States
Sona Nanotech Inc

Terminated

Performance Study of SONA Saliva C-19 Rapid Test

Covid19 | Corona Virus Infection | Sars-CoV-2 Infection

Canada
Kowa Research Institute, Inc.

Recruiting

A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Fuchs Endothelial Corneal Dystrophy

United States, United Kingdom, Spain, Germany, Canada, Denmark
Kowa Research Institute, Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Fuchs Endothelial Corneal Dystrophy

United States, Germany, Spain, Canada, United Kingdom, Denmark
Kowa Research Institute, Inc.

Completed

Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

Dyslipidemia

United States
Kowa Research Institute, Inc.

Completed

Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Withdrawn

Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia

Dyslipidemia | Hyperlipidemia

United States
Kowa Research Institute, Inc.

Completed

Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Terminated

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

Acute Pain From Ankle Sprain or Strain

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

Hyperlipidemia

United States
Kowa Research Institute, Inc.

Completed

Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

Severe Renal Impairment

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin

Healthy

United States
Kowa Research Institute, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

NASH

United States, Canada, Spain, Japan, Bulgaria
Kowa Research Institute, Inc.

Completed

A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

Corneal Edema After Cataract Surgery

United States, Puerto Rico
Kowa Research Institute, Inc.

Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

Severe Hypertriglyceridemia

United States, Hungary, Belarus, Bulgaria, Czechia, Georgia, Poland, Russian Federation, Ukraine
Kowa Research Institute, Inc.

Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Severe Hypertriglyceridemia

United States, Czechia, Belarus, Hungary, Russian Federation, Poland, Bulgaria, Georgia, Ukraine
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin

Healthy Volunteers

United States
Kowa Research Institute, Inc.

Completed

Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.

Healthy

United States
Kowa Research Institute, Inc.

Completed

Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 (OCT)

Glaucoma | Healthy | Retinal Disease

United States
Kowa Research Institute, Inc.

Completed

Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312

Dyslipidemia

United States
Kowa Research Institute, Inc.

Completed

A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers

Hyperlipidemia

United States
Kowa Research Institute, Inc.

Completed

A Thorough Corrected QT Interval Trial

Dyslipidemia

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Health Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

Safety and Tolerability

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin

Healthy

United States
Kowa Research Institute, Inc.

Completed

Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia (PREVAIL-US)

Mixed Dyslipidemia | Primary Dyslipidemia

United States
Kowa Research Institute, Inc.

Completed

A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

Type 2 Diabetes

United States
Kowa Research Institute, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

Primary Biliary Cholangitis

United States, Japan
Kowa Research Institute, Inc.

Completed

A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease

Dry Eye Disease

United States
Kowa Research Institute, Inc.

Completed

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

Healthy

United States
Kowa Research Institute, Inc.

Completed

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

Dry Eye Disease

United States
Kowa Research Institute, Inc.

Completed

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Fuchs' Endothelial Corneal Dystrophy

United States, Australia, Germany, Spain, Denmark
Kowa Research Institute, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower Extremity

Acute Pain

United States
Kowa Research Institute, Inc.

Withdrawn

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

Dyslipidemia | Hyperlipidemia

United States
Kowa Research Institute, Inc.

Completed

Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers

Healthy

United States
Kowa Research Institute, Inc.

Completed

Drug-Drug Interaction Study in Healthy Adult Volunteers

Healthy

United States

3

Subscribe